This book provides a clinically oriented overview on the patho physiological background and the use of bisphosphonates in oncology the clinical development of pamidronate to treat tumor induced hypercalcemia and malignant osteolytic bone disease is demonstrated as well as the results of pivotal studies new important findings on how to best use pamidronate in certain indications are given and put in perspective the author discusses patient management guidelines as well as pharmaco . Bisphosphonates in clinical oncology the development of pamidronate recent results in cancer research 149 band 149 thurlimann beat isbn 9783642641480 kostenloser versand fur alle bucher mit versand und verkauf duch amazon. Recent results cancer res 19991491 113 bisphosphonates in clinical oncology the development of pamidronate thurlmann b pmid 10087580 pubmed indexed for medline publication types review mesh terms adult aged aged 80 and over antineoplastic agents therapeutic use bone diseases drug therapy bone neoplasms drug therapy bone neoplasms secondary bone and bones cytology bone . This book provides a clinically oriented overview on the patho physiological background and the use of bisphosphonates in oncology the clinical development of pamidronate to treat tumor induced hypercalcemia and malignant osteolytic bone disease is demonstrated as well as the results of pivotal. This book provides a clinically oriented overview on the patho physiological background and the use of bisphosphonates in oncology the clinical development of pamidronate to treat tumor induced hypercalcemia and malignant osteolytic bone disease is demonstrated as well as the results of pivotal studies new important findings on how to best use pamidronate in certain indications are given and put in perspective the author discusses patient management guidelines as well as pharmaco